In vitro and in vivo anti-inflammatory active copper(II)-lawsone complexes
Language English Country United States Media electronic-ecollection
Document type Journal Article
PubMed
28742852
PubMed Central
PMC5526570
DOI
10.1371/journal.pone.0181822
PII: PONE-D-17-14225
Knihovny.cz E-resources
- MeSH
- Anti-Inflammatory Agents therapeutic use MeSH
- Edema drug therapy MeSH
- Spectrometry, Mass, Electrospray Ionization MeSH
- Rats MeSH
- Crystallography, X-Ray MeSH
- Humans MeSH
- Copper chemistry therapeutic use MeSH
- Cell Line, Tumor MeSH
- Naphthoquinones chemistry therapeutic use MeSH
- NF-kappa B antagonists & inhibitors MeSH
- Rats, Wistar MeSH
- Dose-Response Relationship, Drug MeSH
- Inflammation drug therapy MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Inflammatory Agents MeSH
- lawsone MeSH Browser
- Copper MeSH
- Naphthoquinones MeSH
- NF-kappa B MeSH
We report in vitro and in vivo anti-inflammatory activities of a series of copper(II)-lawsone complexes of the general composition [Cu(Law)2(LN)x(H2O)(2-x)]·yH2O; where HLaw = 2-hydroxy-1,4-naphthoquinone, x = 1 when LN = pyridine (1) and 2-aminopyridine (3) and x = 2 when LN = imidazole (2), 3-aminopyridine (4), 4-aminopyridine (5), 3-hydroxypyridine (6), and 3,5-dimethylpyrazole (7). The compounds were thoroughly characterized by physical techniques, including single crystal X-ray analysis of complex 2. Some of the complexes showed the ability to suppress significantly the activation of nuclear factor κB (NF-κB) both by lipopolysaccharide (LPS) and TNF-alpha (complexes 3-7 at 100 nM level) in the similar manner as the reference drug prednisone (at 1 μM level). On the other hand, all the complexes 1-7 decreased significantly the levels of the secreted TNF-alpha after the LPS activation of THP-1 cells, thus showing the anti-inflammatory potential via both NF-κB moderation and by other mechanisms, such as influence on TNF-alpha transcription and/or translation and/or secretion. In addition, a strong intracellular pro-oxidative effect of all the complexes has been found at 100 nM dose in vitro. The ability to suppress the inflammatory response, caused by the subcutaneous application of λ-carrageenan, has been determined by in vivo testing in hind-paw edema model on rats. The most active complexes 1-3 (applied in a dose corresponding to 40 μmol Cu/kg), diminished the formation of edema simalarly as the reference drug indomethacine (applied in 10 mg/kg dose). The overall effect of the complexes, dominantly 1-3, shows similarity to anti-inflammatory drug benoxaprofen, known to induce intracellular pro-oxidative effects.
See more in PubMed
Pradhan R, Dandawate P, Vyas A, Padhye S, Biersack B, Schobert R, et al. From Body Art to Anticancer Activities: Perspectives on Medicinal Properties of Henna, Curr. Drug Targets 2012; 13: 1777–1798. PubMed
Singh DK, Luqman S, Mathur AK. Lawsonia inermis L.–A commercially important primaeval dying and medicinal plant with diverse pharmacological activity: A review. Ind. Crop. Prod. 2015; 65: 269–286.
Biradar S, Veeresh B. Protective effect of lawsone on L-Arginine induced acute pancreatitis in rats. Indian J. Exp. Biol. 2013; 51: 256–261. PubMed
Ali BH, Bashir AK, Tanira MOM. Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L (Henna) in rats. Pharmacology 1995; 51: 356–363. PubMed
Marzin D, Kirkland D. 2-Hydroxy-1,4-naphthoquinone, the natural dye of Henna, is non-genotoxic in the mouse bone marrow micronucleus test and does not produce oxidative DNA damage in Chinese hamster ovary cells. Mutat. Res. 2004; 560: 41–47. doi: 10.1016/j.mrgentox.2004.02.004 PubMed DOI
Salunke-Gawali S, Rane S, Boukheddaden K, Codjovi E, Linares J, Varret F, et al. Thermal, magnetic and electrochemical properties of polymeric copper complexes of 2-hydroxy-1,4-naphthoquinone and its methyl derivative. Ind. J. Chem. 2004; 43A: 2563–2567.
Tabrizi L, Talaie F, Chiniforoshan H. Copper(II), cobalt(II) and nickel(II) complexes of lapachol: synthesis, DNA interaction, and cytotoxicity. J. Biomol. Struct. Dyn. 2017. Accepted paper doi: doi: 10.1080/07391102.2016.1254118 PubMed DOI
Valle-Bourrouet G, Ugalde-Saldívar VM, Gómez M, Ortiz-Frade LA, González I, Frontana C. Magnetic interactions as a stabilizing factor of semiquinone species of lawsone by metal complexation. Electrochim. Acta 2010; 55: 9042–9050.
Brandelli A, Bizani D, Martinelli M, Stefani V, Gerbase AE. Antimicrobial activity of 1,4-naphthoquinones by metal complexation. Brazil. J. Pharm. Sci. 2004; 40: 247–253.
Oramas-Royo S, Torrejón C, Cuadrado I, Hernández-Molina R, Hortelano S, Estévez-Braun A, et al. Synthesis and cytotoxic activity of metallic complexes of lawsone. Bioorg. Med. Chem. 2013; 21: 2471–2477. doi: 10.1016/j.bmc.2013.03.002 PubMed DOI
Tabrizi L, Fooladivanda M, Chiniforoshan H. Copper(II), cobalt(II) and nickel(II) complexes of juglone: synthesis, structure, DNA interaction and enhanced cytotoxicity. Biometals 2016; 29: 981–993. doi: 10.1007/s10534-016-9970-0 PubMed DOI
Babula P, Vanco J, Krejcova L, Hynek D, Sochor J, Adam V, et al. Voltammetric Characterization of Lawsone-Copper(II) Ternary Complexes and Their Interactions with dsDNA. Int. J. Electrochem. Sci. 2012; 7: 7349–7366.
Salunke-Gawali S, Rane SY, Puranik VG, Guyard-Duhayon C, Varret F. Three dimensional hydrogen-bonding network in a copper complex of 2-hydroxy-1,4-naphthoquinone: structural, spectroscopic and magnetic properties. Polyhedron 2004; 23: 2541–2547.
Bruker. Apex3. Bruker AXS Inc., Madison, Wisconsin, USA, 2015.
Sheldrick GM. Crystal structure refinement with SHELXL. Acta Crystallogr. C 2015; 71: 3–8. PubMed PMC
Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, et al. Mercury CSD 2.0—New features for the visualisation and investigation of crystal structures. J. Appl. Crystallogr. 2008; 41: 466–470.
Vanco J, Galikova J, Hosek J, Dvorak Z, Parakova L, Travnicek Z. Gold(I) Complexes of 9-Deazahypoxanthine as Selective Antitumor and Anti-Inflammatory Agents. Plos One 2014; 9: e109901 doi: 10.1371/journal.pone.0109901 PubMed DOI PMC
Wang H, Joseph JA. Quantifying Cellular Oxidative Stress by Dichlorofluorescein Assay using Microplate Reader. Free Rad. Biol. Med. 1999; 27: 612–616. PubMed
Kalyanaraman B, Darley-Usmar V, Davies KJA, Dennery PA, Forman HJ, Grisham MB, et al. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Rad. Biol. Med. 2012; 52: 1–6. doi: 10.1016/j.freeradbiomed.2011.09.030 PubMed DOI PMC
Garber JC, Barbee RW, Bielitzki JT, Clayton LA, Donovan JC, et al. Guide for the Care and Use of Laboratory Animals, 8th ed., Washington: The National Academies Press, USA, 2011, 246 p.
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109–110. PubMed
Chang HZ, Sheu MJ, Yang CH, Leu ZC, Chang YS, Peng WH, et al. Analgesic effects and the mechanisms of anti-inflammation of hispolon in mice. Evid. Based Complement. Alternat. Med. 2011; Article ID 478246. PubMed PMC
Pouchert ChJ. The Aldrich Library of Infrared Spectra, 3rd ed., Aldrich Chemical Company, Milwaukee, USA, 1981, 1873 p.
Lever ABP. Inorganic Electronic Spectroscopy, 2nd ed., Elsevier Publishing Co., Amsterdam, 1984.
Bondi A. van der Waals Volumes and Radii. J. Phys. Rev. 1964; 68: 441–451.
Casanova I, Sousa-Pedrares A, Viqueira J, Duran ML, Romero J, Sousa A, et al. Electrochemical synthesis and structural characterization of homoleptic and heteroleptic cobalt, nickel, copper, zinc and cadmium compounds with the 2-hydroxy-1,4-naphthoquinone ligand. New J. Chem. 2013; 37: 2303–2316.
Singh S, Srivastava NM, Modi NT, Saifi AQ. Anti-inflammatory activity of Lawsonia inermis. Curr. Sci. 1982; 51: 470–471.
Semwal RB, Semwal DK, Combrinck S, Cartwright-Jones C, Viljoen A. Lawsonia inermis L. (henna): Ethnobotanical, phytochemical and pharmacological aspects. J. Ethnopharmacol. 2014; 155: 80–103. doi: 10.1016/j.jep.2014.05.042 PubMed DOI
Duncan C, White AR. Copper complexes as therapeutic agents. Metallomics 2012; 4: 127–138. doi: 10.1039/c2mt00174h PubMed DOI
Medici S, Peana M, Nurchi VM, Lachowicz JI, Crisponi G, Zoroddu MA. Noble metals in medicine: latest advances. Coord. Chem. Rev. 284 (2015) 329–350.
Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001; 13: 85–94. PubMed
Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285: 736–739. PubMed
Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. PNAS 2000; 97: 13766–13771. doi: 10.1073/pnas.250476497 PubMed DOI PMC
Galati G, Tafazoli S, Sabzevari O, Chan TS, O'Brien PJ. Idiosyncratic NSAID drug induced oxidative stress. Chem. Biol. Interact. 2002; 142: 25–41. PubMed
Miyamoto G, Zahid N, Uetrecht JP. Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem. Res. Toxicol. 1997; 10: 414–419. doi: 10.1021/tx960190k PubMed DOI
Van Rensburg AJ, Theron AJ, Anderson R. Comparison of the pro-oxidative interactions of flunoxaprofen and benoxaprofen with human polymorphonuclear leucocytes in vitro. Agents Actions 1991; 33: 292–299. PubMed
Lukey PT, Anderson R, Dippenaar UH, Benoxaprofen activates membrane-associated oxidative metabolism in human polymorphonuclear leucocytes by apparent modulation of protein kinase C. Br. J. Pharmacol. 1988; 93: 289–294. PubMed PMC
Zelova H, Hosek J. TNF-α signalling and inflammation: Interactions between old acquaintances. Inflamm. Res. 2013; 62: 641–651. doi: 10.1007/s00011-013-0633-0 PubMed DOI
Kobayashi K, Nishiumi S, Nishida M, Hirai M, Azuma T, Yoshida H, et al. Effects of quinone derivatives, such as 1,4-naphthoquinone, on DNA polymerase inhibition and anti-inflammatory action. Med. Chem. 2011; 7: 37–44. PubMed
McKallip RJ, Lombard C, Sun JP, Ramakrishnan R. Toxicology and applied pharmacology 2010; 247: 41–52. doi: 10.1016/j.taap.2010.05.013 PubMed DOI
Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011; 21: 103–115. doi: 10.1038/cr.2010.178 PubMed DOI PMC
Stanley AC, Lacy P. Pathways for Cytokine Secretion. Physiology 2010; 25: 218–229. doi: 10.1152/physiol.00017.2010 PubMed DOI
Hawley RC, Labadie SS, Sjogren EB, Talamas FX. Aminopyrimidine and Aminopyridine Anti-Inflammation Agents. US Patent No. US 6,846,828 B2, 2005.
Franciosi S, Ryu JK, Choi HB, Radov L, Kim SU, McLarnon JG. Broad-Spectrum Effects of 4-Aminopyridine to Modulate Amyloid β1–42-Induced Cell Signaling and Functional Responses in Human Microglia. J. Neurosci. 2006; 26: 11652–11664. doi: 10.1523/JNEUROSCI.2490-06.2006 PubMed DOI PMC
Uetrecht JP. Myeloperoxidase as a generator of drug free radicals. Biochem. Soc. Symp. 1995; 61: 163–170. PubMed
Investigation of Anti-Inflammatory Potential of N-Arylcinnamamide Derivatives